EW Share Price

Open 81.44 Change Price %
High 84.66 1 Day 1.88 2.31
Low 81.25 1 Week -0.95 -1.13
Close 83.35 1 Month -6.28 -7.01
Volume 2324500 1 Year -78.67 -48.56
52 Week High 165.97
52 Week Low 72.20
EW Important Levels
Resistance 2 86.51
Resistance 1 85.21
Pivot 83.09
Support 1 81.49
Support 2 80.19
NYSE USA Most Active Stocks
BAC 21.23 -1.26%
BAC 21.23 -1.26%
BAC 21.23 -1.26%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
VNR 0.91 19.74%
VNR 0.91 19.74%
P 13.33 16.11%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Edwards Lifesciences Corporation (NYSE: EW)

EW Technical Analysis 5
As on 2nd Dec 2016 EW Share Price closed @ 83.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 99.73 & Strong Sell for SHORT-TERM with Stoploss of 104.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
EW Target for December
1st Target up-side 89.88
2nd Target up-side 94.8
3rd Target up-side 99.72
1st Target down-side 75.82
2nd Target down-side 70.9
3rd Target down-side 65.98
EW Other Details
Segment EQ
Market Capital 10420026368.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.edwards.com
EW Address
EW
One Edwards Way
Irvine, CA 92614
United States
Phone: 949-250-2500
Fax: 949-250-2525
EW Latest News
Interactive Technical Analysis Chart Edwards Lifesciences Corporation ( EW NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Edwards Lifesciences Corporation
EW Business Profile
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient’s diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect patients and clinicians from the risk of infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.